CD274 and neoplasm: Conversely, HDACis also decrease the abundance of tumour-associated cells, such as myeloid-derived suppressor cells (MDSCs), and increase the expression of PD-L1 and PD-L2 [30] while concurrently increasing the efficacy of ICB therapies such as PD-1 blockade [31, 32].